Given the fact that IL-6 was one of the most induced cytokines in the context of cancer immunotherapy (ICB and adoptive therapy), we wanted to evaluate whether the IL-6/STAT3 axis could in fact be upregulating SMG1. The gene discussed is IL6; the disease is cancer.